Overview of the Gallbladder Cancer - Pipeline Review, H2 2016: Market Research Report Analysis, Risk factors, Forecast

ResearchMoz added Latest Research Report titled " Gallbladder Cancer - Pipeline Review, H2 2016 " to it's Large Report database.

Gallbladder Cancer - Pipeline Review, H2 2016

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gallbladder Cancer Pipeline Review, H2 2016, provides an overview of the Gallbladder Cancer (Oncology) pipeline landscape.

Gallbladder cancer is a cancer that starts in the gallbladder. Symptoms include abdominal pain, nausea and/or vomiting, jaundice, loss of appetite, fever, itchy skin, dark urine and weight loss. Risk factors include overweight, age, family history, gallstones, gender and choledochal cysts. Treatment includes surgery, chemotherapy and radiation therapy.

Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=889483

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Gallbladder Cancer Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Gallbladder Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Gallbladder Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Gallbladder Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II and Phase I stages are 7 and 2 respectively. Similarly, the Universities portfolio in Phase I stages comprises 1 molecules, respectively.Gallbladder Cancer.

Read All Cancer Market Research Reports @ http://www.researchmoz.us/cancer-market-reports.html

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Gallbladder Cancer Overview 6
Therapeutics Development 7
Pipeline Products for Gallbladder Cancer - Overview 7
Pipeline Products for Gallbladder Cancer - Comparative Analysis 8
Gallbladder Cancer - Therapeutics under Development by Companies 9
Gallbladder Cancer - Therapeutics under Investigation by Universities/Institutes 10
Gallbladder Cancer - Pipeline Products Glance 11
Clinical Stage Products 11
Gallbladder Cancer - Products under Development by Companies 12
Gallbladder Cancer - Products under Investigation by Universities/Institutes 13
Gallbladder Cancer - Companies Involved in Therapeutics Development 14
4SC AG 14
harma Inc 14
BeiGene Ltd 16
Eli Lilly and Company 17
Novartis AG 18
VasGene Therapeutics Inc 19
Gallbladder Cancer - Therapeutics Assessment 20
Assessment by Monotherapy Products 20

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/